NCT00396604View on ClinicalTrials.gov

Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Pulmonary Disease, Chronic ObstructiveCOPDLung Diseases, Obstructive
Interventions
DRUG

indacaterol maleate

Trial Locations (1)

Unknown

Novartis, Vilvoorde

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY